SCHEMBL18263291

SCHEMBL18263291

CCC[C@H]1COC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28363554 1.00
SCHEMBL12641503 1.00
SCHEMBL5988542 0.90 CYP1A2 (0.62)
SCHEMBL5105796 0.90 CYP1A2 (0.62)
SCHEMBL28237732 0.88 CYP1A2 (0.71)
SCHEMBL8710704 0.88 CYP1A2 (0.71)
SCHEMBL28238797 0.88 CYP1A2 (0.71)
SCHEMBL664978 0.86 CYP1A2 (0.69)
SCHEMBL6662416 0.86 CYP1A2 (0.69)
SCHEMBL28296028 0.86 CYP1A2 (0.69)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119876055-A Alkene reductase mutant and application thereof in preparation of buvaracetam intermediate 华东理工大学 2025-04-25 CN claimed
CN-119432782-A Alkene reductase mutant and application thereof in catalytic preparation of buvaracetam synthesis intermediate 上海医药工业研究院有限公司 2025-02-14 CN claimed
CN-119265149-A Ketene reductase and method for preparing buvaracetam intermediate by using same 弈柯莱生物科技(集团)股份有限公司 2025-01-07 CN claimed
CN-115466233-B Synthesis method of buvaracetam intermediate (R) -4-propyl-dihydrofuran-2-one 合肥立方制药股份有限公司 2024-08-23 CN claimed
CN-117701649-B Synthesis method of buvaracetam key intermediate 山东静远药业有限公司 2024-06-14 CN claimed
CN-116948997-B Olefin reductase mutant and application thereof in preparation of (R) -4-propyldihydrofuran-2 (3H) -ketone 江南大学 2024-05-24 CN claimed
CN-117964584-A Synthesis method of (R) -4-propyl-dihydrofuran-2-one 江苏同禾药业有限公司 2024-05-03 CN claimed
CN-114751849-B Preparation method of brivaracetam and intermediate compound 四川奥邦古得药业有限公司 2024-03-22 CN claimed
CN-117701649-A Synthesis method of buvaracetam key intermediate 山东静远药业有限公司 2024-03-15 CN claimed
CN-117658956-A Preparation method of chiral (R) -4-n-propyl-dihydrofuran-2 (3H) -ketone 新天地医药技术研究院(郑州)有限公司 2024-03-08 CN claimed
CN-112521352-A Preparation method of brivaracetam intermediate 北京万全德众医药生物技术有限公司 2021-03-19 CN claimed
CN-112521351-A Preparation method of brivaracetam intermediate 北京万全德众医药生物技术有限公司 2021-03-19 CN claimed
CN-109266630-B Lipase and application thereof in preparation of brivaracetam intermediate 弈柯莱生物科技(上海)股份有限公司 2021-02-02 CN claimed
CN-112062740-A Synthesis method of (R) -4-propyl dihydrofuran-2-ketone 深圳市华先医药科技有限公司 2020-12-11 CN claimed
CN-111693634-A Gas chromatography detection method of related substances of brivaracetam intermediate 万全万特制药(厦门)有限公司 2020-09-22 CN claimed
CN-111349007-A Preparation method of (R) -4-propyl-dihydrofuran-2-ketone and preparation intermediate thereof 浙江京新药业股份有限公司 2020-06-30 CN claimed
CN-108530402-B Preparation method of (R) -3-propyl-gamma-butyrolactone 浙江工业大学 2020-06-26 CN claimed
CN-108203419-B Preparation method of brivaracetam intermediate 浙江京新药业股份有限公司 2020-04-28 CN claimed
CN-108503609-B Method for preparing optically pure (R) -4-n-propyl-dihydrofuran-2 (3H) -ketone 北京艾百诺医药股份有限公司 2019-12-24 CN claimed
EP-3543229-A1 METHOD FOR PREPARING OPTICALLY PURE (R)-4-N-PROPYL-DIHYDROFURAN-2(3H)-ONE Beijing AblePharmtech Co., Ltd. (CN) 2019-09-25 EP claimed